Sensitive and rapid quantification of exosomes by fusing luciferase to exosome marker proteins

[1]  Mohammadreza Sharifi,et al.  Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities , 2018, Journal of cellular physiology.

[2]  M. Ghahremani,et al.  Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.

[3]  André M. N. Silva,et al.  Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation , 2018, Nature Cell Biology.

[4]  Byeong-Cheol Ahn,et al.  An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles , 2018, Front. Pharmacol..

[5]  Takamasa Ishidome,et al.  High Purity Isolation and Sensitive Quantification of Extracellular Vesicles Using Affinity to TIM4 , 2017, Current protocols in cell biology.

[6]  Shih-Ying Wu,et al.  Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[7]  J. Fafián-Labora,et al.  Technical Advances to Study Extracellular Vesicles , 2017, Front. Mol. Biosci..

[8]  Hui-wang Ai,et al.  Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging , 2017, Nature Methods.

[9]  A. Llorente,et al.  Size and concentration analyses of extracellular vesicles by nanoparticle tracking analysis: a variation study , 2017, Journal of extracellular vesicles.

[10]  J. Hung,et al.  Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1 , 2017, Oncogene.

[11]  T. Ochiya,et al.  Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Pieter Vader,et al.  Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.

[13]  Claire Heichette,et al.  Trehalose prevents aggregation of exosomes and cryodamage , 2016, Scientific Reports.

[14]  Diego Diez,et al.  A novel affinity-based method for the isolation of highly purified extracellular vesicles , 2016, Scientific Reports.

[15]  G. Banting,et al.  Tetherin is an exosomal tether , 2016, eLife.

[16]  Ling Li,et al.  Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype. , 2016, Cancer research.

[17]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[18]  M. Okada,et al.  Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression , 2016, Oncogene.

[19]  G. Berchem,et al.  Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer , 2015, Oncoimmunology.

[20]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[21]  Y. Miao,et al.  A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion , 2015, Cell.

[22]  Ralph Weissleder,et al.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.

[23]  Yusuke Yoshioka,et al.  Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier , 2015, Nature Communications.

[24]  A. Di Giannatale,et al.  The New Deal: A Potential Role for Secreted Vesicles in Innate Immunity and Tumor Progression , 2015, Front. Immunol..

[25]  M. Yáñez-Mó,et al.  Tetraspanins in Extracellular Vesicle Formation and Function , 2014, Front. Immunol..

[26]  H. Nakagawa,et al.  Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes , 2014, Scientific Reports.

[27]  K. O'Byrne,et al.  Functions and Therapeutic Roles of Exosomes in Cancer , 2014, Front. Oncol..

[28]  Diane M Simeone,et al.  Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. , 2014, Lab on a chip.

[29]  Hakho Lee,et al.  Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.

[30]  Yusuke Yoshioka,et al.  Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen , 2014, Nature Communications.

[31]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[32]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[33]  Winston Patrick Kuo,et al.  Current methods for the isolation of extracellular vesicles , 2013, Biological chemistry.

[34]  Yusuke Yoshioka,et al.  Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis , 2013, The Journal of Biological Chemistry.

[35]  N. Kosaka,et al.  Comparative marker analysis of extracellular vesicles in different human cancer types , 2013, Journal of extracellular vesicles.

[36]  D. Farber,et al.  Embryonic Stem Cell-Derived Microvesicles Induce Gene Expression Changes in Müller Cells of the Retina , 2012, PloS one.

[37]  M. Michael,et al.  Hypoxic enhancement of exosome release by breast cancer cells , 2012, BMC Cancer.

[38]  Brock F. Binkowski,et al.  Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.

[39]  C. Chen,et al.  Exosome removal as a therapeutic adjuvant in cancer , 2012, Journal of Translational Medicine.

[40]  Ylva Ivarsson,et al.  Syndecan–syntenin–ALIX regulates the biogenesis of exosomes , 2012, Nature Cell Biology.

[41]  Chris Gardiner,et al.  Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.

[42]  M. Okada,et al.  Purvalanol A, a CDK inhibitor, effectively suppresses Src‐mediated transformation by inhibiting both CDKs and c‐Src , 2010, Genes to cells : devoted to molecular & cellular mechanisms.

[43]  T. Wurdinger,et al.  Microfluidic isolation and transcriptome analysis of serum microvesicles. , 2010, Lab on a chip.

[44]  Judith Klumperman,et al.  Trafficking and function of the tetraspanin CD63. , 2009, Experimental cell research.

[45]  Massimo Spada,et al.  High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients , 2009, PloS one.

[46]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[47]  A. Tarakhovsky,et al.  The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src. , 2008, Molecular cell.

[48]  S. Nada,et al.  Functional dissection of transformation by c‐Src and v‐Src , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[49]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[50]  J Ratajczak,et al.  Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.

[51]  R. Weissleder,et al.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  M. Vidal,et al.  Exosome Release Is Regulated by a Calcium-dependent Mechanism in K562 Cells* , 2003, Journal of Biological Chemistry.

[53]  Douglas D. Taylor,et al.  Shed membrane fragment-associated markers for endometrial and ovarian cancers. , 2002, Gynecologic oncology.

[54]  Douglas D. Taylor,et al.  Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers , 2002 .

[55]  Sheila M. Thomas,et al.  Specific and redundant roles of Src and Fyn in organizing the cytoskeleton , 1995, Nature.

[56]  Douglas D. Taylor,et al.  Characterization of plasma membrane shedding from murine melanoma cells , 1988, International journal of cancer.

[57]  J. Gruenberg,et al.  ALIX and the multivesicular endosome: ALIX in Wonderland. , 2014, Trends in cell biology.

[58]  M. Kusano,et al.  New Frontiers in Regenerative Medicine , 2007 .